{"version":"1.0","provider_name":"Revue Internationale d&#039;Intelligence Economique","provider_url":"https:\/\/www.r2ie.org","author_name":"Revue Internationale d&#039;Intelligence Economique","author_url":"https:\/\/www.r2ie.org","title":"Le Danemark, dop\u00e9 par la pharmacie ? - Revue Internationale d&#039;Intelligence Economique","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"DqhzKToDJs\"><a href=\"https:\/\/www.r2ie.org\/index.php\/2023\/11\/09\/le-danemark-dope-par-la-pharmacie\/\">Le Danemark, dop\u00e9 par la pharmacie ?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.r2ie.org\/index.php\/2023\/11\/09\/le-danemark-dope-par-la-pharmacie\/embed\/#?secret=DqhzKToDJs\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Le Danemark, dop\u00e9 par la pharmacie ?\u00a0\u00bb &#8212; Revue Internationale d&#039;Intelligence Economique\" data-secret=\"DqhzKToDJs\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.r2ie.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Le laboratoire danois Novo Nordisk conna\u00eet une croissance sans pr\u00e9c\u00e9dent gr\u00e2ce \u00e0 l\u2019Ozempic et au Wegovy, deux m\u00e9dicaments popularis\u00e9s par les r\u00e9seaux sociaux. Retour sur cette ascension fulgurante, qui ne serait pas sans incidence sur l\u2019\u00e9conomie du Danemark. L\u2019article Le Danemark, dop\u00e9 par la pharmacie ? est apparu en premier sur Portail de l&rsquo;IE.\u00a0Read More\u00a0Portail..."}